Early Renoprotective Effect of Ruxolitinib in a Rat Model of Diabetic Nephropathy

Diabetic kidney disease (DKD) is still one of the unresolved major complications of diabetes mellitus, which leads ultimately to end-stage renal disease in both type 1 and type 2 diabetes patients. Available drugs that suppress the renin–angiotensin system have partially minimized the disease impact...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Kady, Mohamed M., Naggar, Reham A., Guimei, Maha, Talaat, Iman M., Shaker, Olfat G., Saber-Ayad, Maha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308627/
https://www.ncbi.nlm.nih.gov/pubmed/34202668
http://dx.doi.org/10.3390/ph14070608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308627/
https://www.ncbi.nlm.nih.gov/pubmed/34202668
http://dx.doi.org/10.3390/ph14070608

Ejemplares similares